The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Cohen, Russell D.
Item TypeName
Academic Article An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease.
Academic Article Predictors of adalimumab dose escalation in patients with Crohn's disease at a tertiary referral center.
Academic Article Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.
Academic Article Managing immunogenic responses to infliximab: treatment implications for patients with Crohn's disease.
Academic Article Infliximab in ulcerative colitis: is there a placebo (effect) in the house?
Academic Article The incidence and predictors of lupus-like reaction in patients with IBD treated with anti-TNF therapies.
Academic Article Drug therapies and the risk of malignancy in Crohn's disease: results from the TREATâ„¢ Registry.
Academic Article Serum 25-hydroxyvitamin D concentration is inversely associated with mucosal inflammation in patients with ulcerative colitis.
Academic Article Vedolizumab as Induction and Maintenance for Inflammatory Bowel Disease: 12-month Effectiveness and Safety.
Academic Article Pregnancy Outcomes Reported During the 13-Year TREAT Registry: A Descriptive Report.
Academic Article The Use of Vedolizumab in Preventing Postoperative Recurrence of Crohn's Disease.
Academic Article The Effect of Maternal Peripartum Anti-TNFa Use on Infant Immune Response.
Academic Article Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
Academic Article Maneuvering Clinical Pathways for Crohn's Disease.
Academic Article Efficacy and safety of repeated infliximab infusions for Crohn's disease: 1-year clinical experience.
Academic Article Outcome of elective switching to vedolizumab in inflammatory bowel disease patients under tumor necrosis factor antagonist-maintained clinical remission.
Academic Article Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel disease.
Academic Article Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease.
Academic Article Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
Academic Article Prospective Cohort Study to Investigate the Safety of Preoperative Tumor Necrosis Factor Inhibitor Exposure in Patients With Inflammatory Bowel Disease Undergoing Intra-abdominal Surgery.
Search Criteria
  • Tumor Necrosis Factor alpha